carbon monoxide has been researched along with Postoperative Complications in 41 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although this is in line with previous systemic CO dosing protocols, GI muscular inflammation and transit retardation by small intestinal manipulation, performed at 1 h after gavage of 20 tablets, was not prevented while the positive control - intravenous nitrite - prevented POI." | 5.48 | Investigation of orally delivered carbon monoxide for postoperative ileus. ( Lefebvre, RA; Meinel, L; Steiger, C; Van Dingenen, J; Zehe, M, 2018) |
| " An effective dosing regimen was then selected for testing in swine." | 5.33 | Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. ( Bauer, AJ; Choi, AM; Ifedigbo, E; Moore, BA; Otterbein, LE; Overhaus, M; Whitcomb, J, 2005) |
| "Treatment with carbon monoxide (CO) inhalation has been shown to ameliorate postoperative ileus (POI) in rodents and swine." | 3.75 | Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. ( Blanckaert, B; De Backer, O; Elinck, E; Lefebvre, RA; Leybaert, L; Motterlini, R, 2009) |
| " In multivariate analysis, chronic graft-versus-host disease (relative risk, 16) and pretransplantation diffusion capacity for carbon monoxide or forced expiratory volume in the first second <80% predicted were independently associated with a late decrease in PF from baseline (relative risk, 7)." | 3.73 | Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. ( Barrett, AJ; Childs, R; Karimpour, S; Mielke, S; Montero, A; Rezvani, K; Savani, BN; Shenoy, A; Singh, A; Srinivasan, R, 2006) |
| "Methylene blue is an agent thought to help reverse the effects of methemoglobinemia by facilitating the methemoglobin reductase system." | 2.49 | Methemoglobinemia in bronchoscopy: a case series and a review of the literature. ( Bowling, M; Brown, C, 2013) |
| "As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased." | 1.91 | Feasibility analysis of combined surgery for esophageal cancer. ( Huang, C; Li, K; Li, X; Liu, X; Sun, S; Wang, Z; Zhang, G, 2023) |
| " Although this is in line with previous systemic CO dosing protocols, GI muscular inflammation and transit retardation by small intestinal manipulation, performed at 1 h after gavage of 20 tablets, was not prevented while the positive control - intravenous nitrite - prevented POI." | 1.48 | Investigation of orally delivered carbon monoxide for postoperative ileus. ( Lefebvre, RA; Meinel, L; Steiger, C; Van Dingenen, J; Zehe, M, 2018) |
| " An effective dosing regimen was then selected for testing in swine." | 1.33 | Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. ( Bauer, AJ; Choi, AM; Ifedigbo, E; Moore, BA; Otterbein, LE; Overhaus, M; Whitcomb, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (12.20) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 16 (39.02) | 29.6817 |
| 2010's | 14 (34.15) | 24.3611 |
| 2020's | 4 (9.76) | 2.80 |
| Authors | Studies |
|---|---|
| Karush, JM | 1 |
| Alex, G | 1 |
| Geissen, N | 1 |
| Wakefield, C | 1 |
| Basu, S | 1 |
| Liptay, MJ | 1 |
| Seder, CW | 1 |
| Wang, XW | 1 |
| Li, LJ | 1 |
| Huan, C | 1 |
| Chen, D | 1 |
| Du, M | 1 |
| Wu, QC | 1 |
| Wang, Z | 1 |
| Sun, S | 1 |
| Li, K | 1 |
| Huang, C | 1 |
| Liu, X | 1 |
| Zhang, G | 1 |
| Li, X | 1 |
| Su, L | 1 |
| Ho, H | 1 |
| Stock, CT | 1 |
| Quadri, SM | 1 |
| Williamson, C | 1 |
| Servais, EL | 1 |
| Galli, JA | 1 |
| Panetta, NL | 1 |
| Gaeckle, N | 1 |
| Martinez, FJ | 1 |
| Moore, B | 1 |
| Moore, T | 1 |
| Courey, A | 1 |
| Flaherty, K | 1 |
| Criner, GJ | 1 |
| Yoshida, N | 1 |
| Baba, Y | 1 |
| Kuroda, D | 1 |
| Miyamoto, Y | 1 |
| Iwatsuki, M | 1 |
| Hiyoshi, Y | 1 |
| Ishimoto, T | 1 |
| Sawayama, H | 1 |
| Imamura, Y | 1 |
| Watanabe, M | 1 |
| Baba, H | 1 |
| Van Dingenen, J | 1 |
| Steiger, C | 1 |
| Zehe, M | 1 |
| Meinel, L | 1 |
| Lefebvre, RA | 2 |
| Kuwata, T | 1 |
| Shibasaki, I | 1 |
| Ogata, K | 1 |
| Ogawa, H | 1 |
| Takei, Y | 1 |
| Seki, M | 1 |
| Kiriya, Y | 1 |
| Fukuda, H | 1 |
| Novoa, NM | 1 |
| Esteban, P | 1 |
| Gómez Hernández, MT | 1 |
| Fuentes, MG | 1 |
| Varela, G | 1 |
| Jiménez, MF | 1 |
| Elliott, JA | 1 |
| O'Byrne, L | 1 |
| Foley, G | 1 |
| Murphy, CF | 1 |
| Doyle, SL | 1 |
| King, S | 1 |
| Guinan, EM | 1 |
| Ravi, N | 1 |
| Reynolds, JV | 1 |
| Brown, C | 1 |
| Bowling, M | 1 |
| Paul, S | 1 |
| Andrews, WG | 1 |
| Nasar, A | 1 |
| Port, JL | 1 |
| Lee, PC | 1 |
| Stiles, BM | 1 |
| Altorki, NK | 1 |
| Jevtovic-Todorovic, V | 1 |
| De Backer, O | 1 |
| Elinck, E | 1 |
| Blanckaert, B | 1 |
| Leybaert, L | 1 |
| Motterlini, R | 2 |
| Gläser, S | 1 |
| Meyer, R | 1 |
| Opitz, CF | 1 |
| Hetzer, R | 1 |
| Ewert, R | 1 |
| Vos, R | 1 |
| Cordemans, C | 1 |
| Vanaudenaerde, BM | 1 |
| De Vleeschauwer, SI | 1 |
| Schoonis, A | 1 |
| Van Raemdonck, DE | 1 |
| Dupont, LJ | 1 |
| Verleden, GM | 1 |
| Annessi, V | 1 |
| Paci, M | 1 |
| Ricchetti, T | 1 |
| Ferrari, G | 1 |
| Formisano, D | 1 |
| Sgarbi, G | 1 |
| Amar, D | 1 |
| Munoz, D | 1 |
| Shi, W | 1 |
| Zhang, H | 1 |
| Thaler, HT | 1 |
| Takeda, S | 2 |
| Lee, JY | 1 |
| Jin, SM | 1 |
| Lee, CH | 1 |
| Lee, BJ | 1 |
| Kang, CH | 1 |
| Yim, JJ | 1 |
| Kim, YT | 1 |
| Yang, SC | 2 |
| Yoo, CG | 1 |
| Han, SK | 1 |
| Kim, JH | 1 |
| Shim, YS | 1 |
| Kim, YW | 1 |
| D'Journo, XB | 1 |
| Bittar, F | 1 |
| Trousse, D | 1 |
| Gaillat, F | 1 |
| Doddoli, C | 1 |
| Dutau, H | 1 |
| Papazian, L | 1 |
| Raoult, D | 1 |
| Rolain, JM | 1 |
| Thomas, PA | 1 |
| Hooker, CM | 1 |
| Meguid, RA | 1 |
| Hulbert, A | 1 |
| Taylor, JT | 1 |
| Shin, J | 1 |
| Wrangle, J | 1 |
| Rodgers, K | 1 |
| Lee, B | 1 |
| Laskshmanan, S | 1 |
| Brown, T | 1 |
| Meneshian, A | 1 |
| Sussman, M | 1 |
| Keruly, J | 1 |
| Moore, RD | 1 |
| Brock, MV | 1 |
| Myles, PS | 1 |
| Iacono, GA | 1 |
| Hunt, JO | 1 |
| Fletcher, H | 1 |
| Morris, J | 1 |
| McIlroy, D | 1 |
| Fritschi, L | 1 |
| Moore, BA | 2 |
| Otterbein, LE | 2 |
| Türler, A | 1 |
| Choi, AM | 2 |
| Bauer, AJ | 3 |
| Wang, JS | 2 |
| Leo, F | 2 |
| Solli, P | 1 |
| Spaggiari, L | 2 |
| Veronesi, G | 2 |
| de Braud, F | 1 |
| Leon, ME | 1 |
| Pastorino, U | 1 |
| Overhaus, M | 1 |
| Whitcomb, J | 1 |
| Ifedigbo, E | 1 |
| Napolitano, LM | 1 |
| Brunelli, A | 1 |
| Refai, MA | 1 |
| Salati, M | 1 |
| Sabbatini, A | 1 |
| Morgan-Hughes, NJ | 1 |
| Rocco, G | 1 |
| Borri, A | 1 |
| Petrella, F | 1 |
| Gasparri, R | 1 |
| Galetta, D | 1 |
| Funakoshi, Y | 1 |
| Kadota, Y | 1 |
| Koma, M | 1 |
| Maeda, H | 1 |
| Kawamura, S | 1 |
| Matsubara, Y | 1 |
| Nakao, A | 1 |
| Schmidt, J | 1 |
| Harada, T | 1 |
| Tsung, A | 1 |
| Stoffels, B | 1 |
| Cruz, RJ | 1 |
| Kohmoto, J | 1 |
| Peng, X | 1 |
| Tomiyama, K | 1 |
| Murase, N | 1 |
| Fink, MP | 1 |
| Savani, BN | 1 |
| Montero, A | 1 |
| Srinivasan, R | 1 |
| Singh, A | 1 |
| Shenoy, A | 1 |
| Mielke, S | 1 |
| Rezvani, K | 1 |
| Karimpour, S | 1 |
| Childs, R | 1 |
| Barrett, AJ | 1 |
| Pearce, AC | 1 |
| Jones, RM | 1 |
| Cerfolio, RJ | 1 |
| Allen, MS | 1 |
| Trastek, VF | 1 |
| Deschamps, C | 1 |
| Scanlon, PD | 1 |
| Pairolero, PC | 1 |
| Gonzales, A | 1 |
| Foresti, R | 1 |
| Clark, JE | 1 |
| Green, CJ | 1 |
| Winslow, RM | 1 |
| Abboud, RT | 1 |
| Evans, KG | 1 |
| Finley, RJ | 1 |
| Graham, BL | 1 |
| Wright, RR | 1 |
| Tono, M | 1 |
| Pollycove, M | 1 |
| van Son, WJ | 1 |
| Peset, R | 1 |
| Duipmans, JC | 1 |
| van der Mark, TW | 1 |
| The, TH | 1 |
| Tegzess, AM | 1 |
| Pride, NB | 1 |
| Hugh-Jones, P | 1 |
| O'Brien, EN | 1 |
| Smith, LA | 1 |
| Jebavý, P | 1 |
| Widimský, J | 1 |
| Hurych, J | 1 |
| Stanĕk, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis[NCT01071707] | 108 participants (Actual) | Observational | 2009-12-31 | Completed | |||
| Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans Syndrome[NCT01287078] | Phase 2 | 25 participants (Actual) | Interventional | 2011-01-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Participants with progressive disease at baseline with decline in FEV1 greater than 10% (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 2 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with progressive disease at baseline with stablization of FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 2 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable disease at baseline with stablization in FEV1 and greater than 25% decline in systemic immunosuppression (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 3 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants who did not respond to treatment with cyclosporine inhalation solution (CIS) (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 7 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 2 |
Participants who responded to treatment with cyclosporine inhalation solution (CIS) (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 9 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable disease at baseline with stablization of FEV1 and no change or increase in systemic immunosuppresion (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 4 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 2 |
Participants with stable or progressive disease at baseline with greater than 20% of decline in FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 1 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
Participants with stable or progressive disease at baseline with improvement of FEV1 (NCT01287078)
Timeframe: 18 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Inhaled Cyclosporine in HSCT Recipients | 4 |
| Inhaled Cyclosporine in Lung Transplant Recipients | 0 |
1 review available for carbon monoxide and Postoperative Complications
| Article | Year |
|---|---|
Methemoglobinemia in bronchoscopy: a case series and a review of the literature.
Topics: Adult; Anesthetics, Local; Benzocaine; Bronchoscopy; Carbon Monoxide; Child; Cyanosis; Humans; Methe | 2013 |
2 trials available for carbon monoxide and Postoperative Complications
| Article | Year |
|---|---|
Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carboplatin; Chemoradiotherapy, Adj | 2019 |
Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus nonsmokers.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Carbon Monoxide; Cohort Studies; | 2002 |
38 other studies available for carbon monoxide and Postoperative Complications
| Article | Year |
|---|---|
Predicting Non-home Discharge After Lung Surgery: Analysis of the General Thoracic Surgery Database.
Topics: Adolescent; Carbon Monoxide; Humans; Lung; Patient Discharge; Pneumonectomy; Postoperative Complicat | 2023 |
Uniportal video-assisted thoracic S9+10 segmentectomy using a single-direction approach is good for pulmonary function.
Topics: Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pneumonectomy; Postoperativ | 2022 |
Feasibility analysis of combined surgery for esophageal cancer.
Topics: Carbon Monoxide; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Humans; Male; Mid | 2023 |
Surgeon Experience Is Associated With Prolonged Air Leak After Robotic-assisted Pulmonary Lobectomy.
Topics: Carbon Monoxide; Female; Humans; Lung; Lung Neoplasms; Pneumonectomy; Postoperative Complications; R | 2022 |
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.
Topics: Aged; Biopsy; Bronchoscopy; Carbon Monoxide; Disease Progression; Female; Humans; Idiopathic Pulmona | 2017 |
Clinical utility of exhaled carbon monoxide in assessing preoperative smoking status and risks of postoperative morbidity after esophagectomy.
Topics: Aged; Aged, 80 and over; Breath Tests; Carbon Monoxide; Esophageal Neoplasms; Esophagectomy; Exhalat | 2018 |
Investigation of orally delivered carbon monoxide for postoperative ileus.
Topics: Administration, Oral; Animals; Carbon Monoxide; Carboxyhemoglobin; Disease Models, Animal; Drug Deli | 2018 |
Lung-diffusing capacity for carbon monoxide predicts early complications after cardiac surgery.
Topics: Aged; Biomarkers; Carbon Monoxide; Cardiac Surgical Procedures; Female; Hospital Mortality; Humans; | 2019 |
Early exercise pulmonary diffusing capacity of carbon monoxide after anatomical lung resection: a word of caution for fast-track programmes.
Topics: Aged; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Exercise; Humans; Lung; Lung Neoplasms; Middl | 2019 |
Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).
Topics: Aged; Aged, 80 and over; Antimetabolites; Carbon Monoxide; Cohort Studies; Diabetes Complications; F | 2013 |
Good gas, bad gas: isoflurane, carbon monoxide, and which is which?
Topics: Anesthetics, Inhalation; Carbon Monoxide; Gasotransmitters; Humans; Isoflurane; Nerve Degeneration; | 2014 |
Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress.
Topics: Administration, Inhalation; Animals; Carbon Monoxide; Carboxyhemoglobin; Gastrointestinal Transit; H | 2009 |
Pulmonary interstitial and vascular abnormalities following cardiac transplantation.
Topics: Capillaries; Carbon Monoxide; Heart Transplantation; Humans; Lung; Lung Diseases; Postoperative Comp | 2008 |
Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation.
Topics: Adult; Airway Obstruction; Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; C-Reactive Protei | 2009 |
Is age over 70 years a risk factor for pneumonectomy?
Topics: Adenocarcinoma; Adult; Aged; Atrial Fibrillation; Bronchial Fistula; Carbon Monoxide; Carcinoma, Squ | 2009 |
A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer.
Topics: Aged; Anaerobic Threshold; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Car | 2010 |
Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications: DLCO/VA% is More important than predicted postoperative %DLCO?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Coh | 2010 |
Risk factors of postoperative pneumonia after lung cancer surgery.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Carbon Monoxide; Erythrocyte Transf | 2011 |
Molecular detection of microorganisms in distal airways of patients undergoing lung cancer surgery.
Topics: Aged; Carbon Monoxide; Cytomegalovirus; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pne | 2012 |
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
Topics: Adult; Aged; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cohort Studies; | 2012 |
Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine.
Topics: Abdomen; Administration, Inhalation; Animals; Anti-Inflammatory Agents; Carbon Monoxide; Cyclooxygen | 2003 |
Relationship of carbon monoxide pulmonary diffusing capacity to postoperative cardiopulmonary complications in patients undergoing pneumonectomy.
Topics: Adult; Aged; Carbon Monoxide; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pneumonec | 2003 |
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
Topics: Carbon Monoxide; Female; Forced Expiratory Volume; Humans; Lung Neoplasms; Male; Middle Aged; Postop | 2004 |
Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus.
Topics: Administration, Inhalation; Analgesics, Opioid; Analysis of Variance; Animals; Carbon Monoxide; Colo | 2005 |
Carbon monoxide and ileus: inhaled gas to prevent retained gas?
Topics: Abdomen; Administration, Inhalation; Animals; Carbon Monoxide; Disease Models, Animal; Ileus; Postop | 2005 |
Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
Topics: Aged; Carbon Monoxide; Epidemiologic Methods; Female; Forced Expiratory Volume; Humans; Lung Disease | 2006 |
Preoperative chemotherapy and postoperative complications: a closer look.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Cis | 2006 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, La | 2006 |
A single intraperitoneal dose of carbon monoxide-saturated ringer's lactate solution ameliorates postoperative ileus in mice.
Topics: Animals; Benzothiazoles; Blotting, Western; Carbon Monoxide; Carboxyhemoglobin; Diamines; Electropho | 2006 |
Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.
Topics: Adolescent; Adult; Carbon Monoxide; Child; Chronic Disease; Comorbidity; Disease Progression; Female | 2006 |
Smoking and anesthesia: preoperative abstinence and perioperative morbidity.
Topics: Analgesics; Anesthesia; Carbon Monoxide; Carboxyhemoglobin; Cardiovascular System; Hemostasis; Human | 1984 |
Lung resection in patients with compromised pulmonary function.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Carbon Monoxide; Carcinoma; Contraindications; Female; | 1996 |
Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo.
Topics: Acute Disease; Animals; Blood Pressure; Carbon Monoxide; Depression, Chemical; Enzyme Inhibitors; He | 1998 |
Role of CO diffusing capacity during exercise in the preoperative evaluation for lung resection.
Topics: Aged; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Exercise Test; Female; Health Status; Hospita | 2000 |
Blood volume.
Topics: Aged; Blood Volume Determination; Body Constitution; Carbon Monoxide; Central Venous Pressure; Chrom | 1975 |
Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection.
Topics: Adult; Carbon Monoxide; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Lung; Ma | 1987 |
Changes in lung function following the surgical treatment of bullous emphysema.
Topics: Adult; Carbon Dioxide; Carbon Monoxide; Female; Humans; Lung; Lung Compliance; Male; Middle Aged; Ox | 1970 |
Relationship between orthostatic changes of pulmonary diffusing capacity and haemodynamics of lesser circulation.
Topics: Blood Pressure; Carbon Monoxide; Cardiac Output; Catheterization; Diffusion; Heart; Heart Rate; Hemo | 1971 |